Application of NanoBRET target engagement cellular assay for measurement of inhibitor binding to wild type and mutant RAS in live cells

被引:0
|
作者
Wu, Jianghong [1 ]
McGinley, Shawn [1 ]
Wang, Yuan [1 ]
Gallagher, Peter [1 ]
Ma, Haiching [1 ]
机构
[1] React Biol Corp, Malvern, PA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
379
引用
收藏
页数:1
相关论文
共 7 条
  • [1] Application of NanoBRET target engagement cellular assay for development of inhibitors against protein kinases, RAS, and epigenetic proteins in cancer therapy
    Wu, Jianghong
    Wang, Yuan
    McGinley, Shawn
    Gallagher, Peter
    Liang, Li
    Di Lanni, Alisha
    Miles, Ashley
    Haque, Mohammad
    Wan, Yong
    Ma, Haiching
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Exploring the landscape of PARP and PARG inhibitor selectivity in live cells using NanoBRET™ target engagement assays
    Michaud, Ani
    Teske, Kelly
    Wilkinson, Jennifer
    Zimprich, Chad
    Vasta, James
    Corona, Cesear
    Zhou, Min
    Dominguez, Elizabeth
    Dunn-Hoffman, Kaitlin
    Robers, Matthew
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Development of Cell Permeable NanoBRET Probes for the Measurement of PLK1 Target Engagement in Live Cells
    Yang, Xuan
    Smith, Jeffery L.
    Beck, Michael T.
    Wilkinson, Jennifer M.
    Michaud, Ani
    Vasta, James D.
    Robers, Matthew B.
    Willson, Timothy M.
    MOLECULES, 2023, 28 (07):
  • [4] A NanoBRET target engagement assay for querying domain selectivity at full-length polymerase theta in live cells
    Edenson, Steven
    Slater, Michael
    Corona, Cesear
    Beck, Michael
    Vasta, James
    Teske, Kelly
    Michaud, Ani
    Robers, Matthew
    CANCER RESEARCH, 2024, 84 (06)
  • [5] SPRY2 is an inhibitor of the Ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant
    Tsavachidou, D
    Coleman, ML
    Athanasiadis, G
    Li, SX
    Licht, JD
    Olson, MF
    Weber, BL
    CANCER RESEARCH, 2004, 64 (16) : 5556 - 5559
  • [6] MOUSE CELLULAR RETINOIC ACID BINDING-PROTEIN - CLONING, CDNA SEQUENCE AND MESSENGER-RNA EXPRESSION DURING THE RETINOIC ACID-INDUCED DIFFERENTIATION OF F9 WILD-TYPE AND RA-3-10 MUTANT TERATOCARCINOMA CELLS
    STONER, CM
    GUDAS, LJ
    BIOLOGICAL BULLETIN, 1987, 173 (03): : 572 - 572
  • [7] MOUSE CELLULAR RETINOIC ACID BINDING-PROTEIN - CLONING, COMPLEMENTARY-DNA SEQUENCE, AND MESSENGER-RNA EXPRESSION DURING THE RETINOIC ACID-INDUCED DIFFERENTIATION OF F9 WILD-TYPE AND RA-3-10 MUTANT TERATOCARCINOMA CELLS
    STONER, CM
    GUDAS, LJ
    CANCER RESEARCH, 1989, 49 (06) : 1497 - 1504